On ECHEMI
Home > Drugs > Hepatitis B
Hepatitis B
Hepatitis B (viral hepatitis type B, also known as viral hepatitis B) is caused by the hepatitis B virus (HBV), and its clinical manifestations include fatigue, loss of appetite, nausea, vomiting, aversion to oil, hepatomegaly and abnormal liver function. The incidence rate is high in developing countries, and most are asymptomatic, of which one-third show clinical manifestations of liver damage. According to statistics, there are more than 280 million asymptomatic hepatitis B virus carriers (HBsAg carriers) in the world, and about 93 million in my country. Hepatitis B includes the following types: acute hepatitis B (acute icteric hepatitis, acute anicteric hepatitis), chronic hepatitis B, severe hepatitis B, cholestatic hepatitis, post-hepatitis cirrhosis, pediatric hepatitis B virus-related nephritis, neonatal hepatitis B, hepatitis B virus arthritis, etc.
Related Drugs
Matrine Glucose Injection
Indication: Used to restore alanine aminotransferase and bilirubin to normal in patients with chronic hepatitis.
Manufacturer:

Heilongjiang Yudi Pharmaceutical Co., Ltd.

Matrine Glucose Injection
Indication: Used for elevated transaminase and abnormal bilirubin in chronic hepatitis B.
Manufacturer:

Cisen Pharmaceutical Co., Ltd.

Hepatitis B Fuzheng Capsules
Manufacturer:

Jilin Tonghua Boxiang Pharmaceutical Co., Ltd.

Hepatitis B Detoxification Capsules
Manufacturer:

Harbin Pharmaceutical Group Pharmaceutical Factory No.6

Hepatitis B Detoxification Capsules
Manufacturer:

Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory

Hepatitis B Detoxification Capsules
Manufacturer:

Suzhou Yifan Pharmaceutical Co., Ltd.

Hepatitis B Fuzheng Capsules
Manufacturer:

Jianmin Group Yekaitai National Medicine (Suizhou) Co., Ltd.

Hepatitis B Fuzheng Capsules
Manufacturer:

Weihai Life Pharmaceutical Co., Ltd.

TWINRIX- hepatitis a and hepatitis b (recombinant) vaccine_injection, suspension
Indication: TWINRIX is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. TWINRIX is approved for use in persons 18 years of age or older. TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus.
Manufacturer:

GlaxoSmithKline Biologicals SA

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.